Birmingham, West Midlands -- (SBWIRE) -- 12/19/2013 -- Value Penny Stocks issues special report on Geron Corporation (NASDAQ:GERN), American Capital Ltd. (NASDAQ:ACAS), PDL BioPharma Inc. (NASDAQ:PDLI), Depomed Inc (NASDAQ:DEPO).
Geron Corporation (NASDAQ:GERN) opened its last trade at the price of $4.70. Its closing price was $4.69 after losing -0.21% for the day. The company traded with the total volume of 3,278,310 shares, while its average trading volume remained 8.15 million shares. The beta of this stock stands at 1.24. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Has GERN Found The Bottom and Ready To Move Up? Find Out Here
American Capital Ltd. (NASDAQ:ACAS) percentage change surged 2.40% to close at $14.95 with the total traded volume of 3,264,511 shares, along with average volume of 2.16 million shares. The 52 week range of the stock remained $11.81 - $15.41, while its day lowest price was $14.41. The share price hit the day highest price of $15.02. American Capital, Ltd. is a private equity and venture capital firm specializing in management and employee buyouts, leveraged finance, mezzanine, acquisition, recapitalization, middle market, and growth capital investments.
For How Long ACAS’s Gloss will Attract Investors? Find out via this report
PDL BioPharma Inc. (NASDAQ:PDLI) traded on volume of 3,263,591 shares in the last session against average volume of 3.13 million shares. The company started its trading session with the price of $8.12 and closed at $8.38 by scoring +3.84%. PDL BioPharma, Inc. engages in intellectual property asset management and patent portfolio and related assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases, as well as other medical conditions.
Will PDLI Continue To Move Higher? Find Out Here
Depomed Inc (NASDAQ:DEPO) started its last trading session with the price of $8.83 and closed at $9.82 by scoring +17.60%. The stock traded with total volume of 3,169,063 shares, while the average trading volume remained 480.754 million shares. The beta value of this stock stands at 1.07. Day range for the stock was $8.72 - $9.88. Depomed, Inc., a specialty pharmaceutical company, focuses on developing products for pain and other conditions, and diseases of the central nervous system in the United States. The company primarily offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia.
Why Should Investors Buy DEPO After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)